[Treatment of pseudoaneurysms with injection of thrombin]
OBJECTIVES: To introduce and assess the efficacy and risks associated with a new treatment method of post-catheterization pseudoaneurysms. METHODS: Thrombin injection was indicated in patients with failure of compression therapy during 24 hours. Patients with a cavity volume < 1 cm3, with a pseudoaneurysm causing compression or haemorrhagic shock were excluded. A needle is introduced under local anaesthesia with ultrasound guidance, its tip is placed thoroughly in the centre of the cavity. Subsequently, under colour-flow mapping, thrombin solution with concentration of 1000 IU/ml is cautiously injected, which results in instantaneous thrombosis of the pseudoaneurysm cavity. RESULTS: Thrombin injection was used in 17 patients during a period of 12 months. 12 of them were women, 6 patients with valvular disease, 2 after intervention and 5 anticoagulated. The method was successful in 16 patients. In 5 of them, a small residual cavity persisted, which was not suitable for re-injection, and was closed completely after a few minutes of compression by a ultrasound transducer. There were no thrombotic complications. CONCLUSION: Although compression remains the method of choice, thrombin injection is a highly effective, quick and, with necessary precautions, safe alternative to surgical treatment of pseudoaneurysms, mainly in anticoagulated patients.
- MeSH
- arteria femoralis * diagnostické zobrazování zranění MeSH
- hemostatika aplikace a dávkování MeSH
- injekce MeSH
- intervenční ultrasonografie MeSH
- lidé středního věku MeSH
- lidé MeSH
- nepravé aneurysma diagnostické zobrazování etiologie terapie MeSH
- periferní katetrizace škodlivé účinky MeSH
- senioři MeSH
- thrombin aplikace a dávkování MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- hemostatika MeSH
- thrombin MeSH
The nephrotoxicity of various combinations of antibiotics--aminoglycosides, cephalosporins, vancomycin, amphotericin B--in 171 oncologic patients is described. The most nephrotoxic combination seems to be cefotaxime plus gentamicin, ceftriaxone plus amikacin and amphotericin B with cephalosporin, vancomycin or aminoglycoside. Less toxic was netilmicin with penicillin or cephalosporin, and vancomycin.
- MeSH
- amfotericin B škodlivé účinky MeSH
- aminoglykosidy MeSH
- antibakteriální látky škodlivé účinky MeSH
- cefalosporiny škodlivé účinky MeSH
- kombinovaná farmakoterapie škodlivé účinky MeSH
- ledviny účinky léků MeSH
- lidé MeSH
- nádory komplikace MeSH
- retrospektivní studie MeSH
- vankomycin škodlivé účinky MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- amfotericin B MeSH
- aminoglykosidy MeSH
- antibakteriální látky MeSH
- cefalosporiny MeSH
- vankomycin MeSH